CORTEX PHARMACEUTICALS, INC.
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 21, 2010 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 200 Total Citation Count
- Jun 24, 1993 Earliest Filing
- 7 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0267,728 3-SUBSTITUTED-1,2,3-TRIAZIN-4-ONE'S AND 3 SUBSTITUTED 1,3-PYRIMIDINONE'S FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSESAbandonedSep 19, 08Oct 21, 10[A61K, C07D, A61P]
7799913 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responsesExpiredNov 25, 02Sep 21, 10[A61K, C07D, A61P]
2010/0041,647 3-Substituted-[1,2,3]-Benzotriazinone compounds for enhancing glutamatergic synaptic responsesAbandonedDec 28, 07Feb 18, 10[A61K, C07D, A61P]
2006/0276,462 Method of treating cognitive decline due to sleep deprivation and stressAbandonedJan 13, 04Dec 07, 06[A61K, C07D]
2005/0228,019 Enhancement of ampakine-Induced facilitation of synaptic responses by cholinesterase inhibitorsAbandonedJan 26, 05Oct 13, 05[A61K]
5622981 Use of metabotropic receptor agonists in progressive neurodegenerative diseasesExpiredApr 07, 95Apr 22, 97[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.